Spexis provides business update and announces financial
Spexis provides business update and announces financial results for the first half of 2023...
Stay updated with breaking news from Pexis Ag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Spexis provides business update and announces financial results for the first half of 2023...
Ad hoc announcement pursuant to Art. 53 LR ALLSCHWIL, Switzerland, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage...
Ad hoc announcement pursuant to Art. 53 LR Inhaled murepavadin shown to be well tolerated at all dose levels Program derived from Spexis’...
Balixafortide shown to have synergistic or additive effect with conventional or targeted therapies across all tested B-cell lymphomas ALLSCHWIL,...
Investegate announcements from Spexis AG, Spexis to present at BioEquity Europe 2022